Neurocrine Biosciences
NBIX
#1524
Rank
โ‚ฌ11.06 B
Marketcap
110,93ย โ‚ฌ
Share price
1.62%
Change (1 day)
-9.57%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): โ‚ฌ0.47 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are โ‚ฌ2.35 Billion. , an increase over its 2023 earnings that were of โ‚ฌ0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 โ‚ฌ0.49 B64.57%
2023 โ‚ฌ0.29 B41.13%
2022 โ‚ฌ0.21 B73.74%
2021 โ‚ฌ0.12 B-8.82%
2020 โ‚ฌ0.13 B77.78%
2019 โ‚ฌ74.96 M49.83%
2018 โ‚ฌ50.03 M-142.57%
2017 -โ‚ฌ0.12 Billion-14.73%
2016 -โ‚ฌ0.14 Billion53.15%
2015 -โ‚ฌ90.01 Million46.25%
2014 -โ‚ฌ61.54 Million29.66%
2013 -โ‚ฌ47.47 Million-3530.8%
2012 โ‚ฌ1.38 M-95.73%
2011 โ‚ฌ32.4 M
2009 -โ‚ฌ45.56 Million-45.38%
2008 -โ‚ฌ83.41 Million-58.87%
2007 -โ‚ฌ0.21 Billion87.3%
2006 -โ‚ฌ0.11 Billion351.97%
2005 -โ‚ฌ23.96 Million-52.09%
2004 -โ‚ฌ50 Million-10.98%
2003 -โ‚ฌ56.17 Million
2001 -โ‚ฌ41.93 Million
1999 -โ‚ฌ18.91 Million108.32%
1998 -โ‚ฌ9.08 Million
1996 โ‚ฌ2.77 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ18.36 M-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.48 B 203.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
-โ‚ฌ30.9 Million-106.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.69 B 1,877.50%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.87 B 1,302.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.63 B 1,252.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ7.17 Million-101.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ39.9 Million-108.14%๐Ÿ‡บ๐Ÿ‡ธ USA